Teva Pharmaceutical Industries Ltd. (TEVA)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 6 |
Ownership rank: | 66 |
% of all portfolios: | 0.056% |
Hold Price * : | $18.02 |
History | Portfolio Manager | Activity ▲ | Share change | % change to portfolio | |
Q3  2024 | |||||
≡ | Harry Burn - Sound Shore | Reduce 11.60% | 784,602 | 0.46 | |
Q2  2024 | |||||
≡ | Harry Burn - Sound Shore | Reduce 9.78% | 733,244 | 0.40 | |
≡ | Bill Miller - Miller Value Partners | Reduce 5.60% | 650 | 0.01 | |
Q1  2024 | |||||
≡ | Harry Burn - Sound Shore | Reduce 15.97% | 1,424,544 | 0.63 | |
≡ | Bill Miller - Miller Value Partners | Reduce 13.43% | 1,800 | 0.02 | |
≡ | Lee Ainslie - Maverick Capital | Reduce 8.73% | 5,502 | 0.00 | |
≡ | David Abrams - Abrams Capital Management | Sell 100.00% | 5,996,836 | 1.95 | |
Q4  2023 | |||||
≡ | David Abrams - Abrams Capital Management | Reduce 24.72% | 1,969,597 | 0.64 | |
≡ | Samantha McLemore - Patient Capital Management | Reduce 20.00% | 25,000 | 0.02 | |
≡ | Bill Miller - Miller Value Partners | Reduce 5.80% | 825 | 0.01 | |
Q3  2023 | |||||
≡ | Bill Miller - Miller Value Partners | Reduce 82.68% | 67,912 | 0.43 | |
≡ | Samantha McLemore - Patient Capital Management | Reduce 59.16% | 181,054 | 0.12 | |
≡ | Lee Ainslie - Maverick Capital | Reduce 34.56% | 17,483 | 0.01 | |
Q2  2023 | |||||
≡ | Bill Miller - Miller Value Partners | Reduce 97.91% | 3,847,647 | 19.67 | |
≡ | Samantha McLemore - Patient Capital Management | Reduce 51.11% | 319,946 | 0.14 | |
≡ | Lee Ainslie - Maverick Capital | Reduce 4.31% | 2,277 | 0.00 | |
Q1  2023 | |||||
≡ | David Abrams - Abrams Capital Management | Reduce 50.00% | 7,966,432 | 2.23 | |
≡ | Samantha McLemore - Patient Capital Management | Reduce 24.81% | 206,575 | 0.82 | |
≡ | Bill Miller - Miller Value Partners | Reduce 23.65% | 1,217,243 | 0.67 | |
Q4  2022 | |||||
≡ | Bill Miller - Miller Value Partners | Reduce 44.39% | 4,107,848 | 2.42 | |
≡ | David Abrams - Abrams Capital Management | Reduce 33.33% | 7,966,431 | 2.59 | |
≡ | Samantha McLemore - Patient Capital Management | Reduce 29.14% | 342,425 | 1.54 | |
Q3  2022 | |||||
≡ | Samantha McLemore - Patient Capital Management | Reduce 1.50% | 17,950 | 0.07 | |
≡ | Bill Miller - Miller Value Partners | Reduce 0.85% | 79,715 | 0.04 | |
≡ | David Abrams - Abrams Capital Management | Reduce 0.61% | 147,060 | 0.03 | |
Q2  2022 | |||||
≡ | Bill Miller - Miller Value Partners | Reduce 7.20% | 724,149 | 0.30 | |
Q4  2021 | |||||
≡ | Bill Miller - Miller Value Partners | Reduce 0.91% | 88,610 | 0.03 | |
≡ | Warren Buffett - Berkshire Hathaway | Sell 100.00% | 42,789,295 | 0.14 | |
Q3  2021 | |||||
≡ | Bill Miller - Miller Value Partners | Reduce 10.86% | 1,187,654 | 0.39 | |
≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 44,879 | 0.00 | |
Q2  2021 | |||||
≡ | Lee Ainslie - Maverick Capital | Reduce 71.20% | 110,962 | 0.00 | |
≡ | Meridian Contrarian Fund | Sell 100.00% | 1,079,000 | 1.82 | |
Q4  2020 | |||||
≡ | Lee Ainslie - Maverick Capital | Reduce 64.31% | 80,503 | 0.02 | |
≡ | Bill Miller - Miller Value Partners | Reduce 11.79% | 953,998 | 0.31 | |
Q3  2020 | |||||
≡ | Meridian Contrarian Fund | Reduce 21.43% | 147,000 | 0.27 | |
Q2  2020 | |||||
≡ | Bill Miller - Miller Value Partners | Reduce 0.86% | 67,890 | 0.04 | |
Q1  2020 | |||||
≡ | Bill Miller - Miller Value Partners | Reduce 19.48% | 1,915,705 | 1.11 | |
≡ | Warren Buffett - Berkshire Hathaway | Reduce 1.06% | 460,000 | 0.00 | |
≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 461,715 | 0.07 | |
Q4  2019 | |||||
≡ | Lee Ainslie - Maverick Capital | Reduce 30.17% | 199,500 | 0.03 | |
≡ | Francis Chou - Chou Associates | Sell 100.00% | 15,000 | 0.06 | |
Q2  2019 | |||||
≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 94,530 | 0.02 | |
Q1  2019 | |||||
≡ | Lee Ainslie - Maverick Capital | Reduce 60.81% | 146,690 | 0.03 | |
≡ | David Abrams - Abrams Capital Management | Reduce 2.57% | 476,016 | 0.21 | |
Q4  2018 | |||||
≡ | David Abrams - Abrams Capital Management | Reduce 5.12% | 1,000,000 | 0.64 | |
Q3  2018 | |||||
≡ | David Abrams - Abrams Capital Management | Reduce 1.12% | 220,751 | 0.13 | |
Q4  2017 | |||||
≡ | Francis Chou - Chou Associates | Reduce 97.03% | 490,000 | 3.92 | |
≡ | David Abrams - Abrams Capital Management | Reduce 8.70% | 1,880,763 | 1.20 | |
Q2  2017 | |||||
≡ | David Tepper - Appaloosa Management | Sell 100.00% | 2,175,000 | 1.22 | |
Q1  2017 | |||||
≡ | David Tepper - Appaloosa Management | Reduce 56.96% | 2,878,000 | 1.61 | |
≡ | David Katz - Matrix Asset Advisors | Sell 100.00% | 37,500 | 2.30 | |
Q1  2016 | |||||
≡ | David Katz - Matrix Asset Advisors | Reduce 14.10% | 5,500 | 0.52 | |
Q2  2015 | |||||
≡ | David Katz - Matrix Asset Advisors | Reduce 4.18% | 1,700 | 0.14 | |
Q4  2014 | |||||
≡ | Thomas Gayner - Markel Group | Sell 100.00% | 444,000 | 0.67 | |
Q3  2014 | |||||
≡ | Thomas Gayner - Markel Group | Reduce 36.02% | 250,000 | 0.38 | |
Q2  2014 | |||||
≡ | David Katz - Matrix Asset Advisors | Reduce 3.61% | 1,500 | 0.10 | |
Q1  2014 | |||||
≡ | David Katz - Matrix Asset Advisors | Reduce 23.15% | 12,500 | 0.80 | |
≡ | Thomas Gayner - Markel Group | Reduce 0.84% | 5,900 | 0.01 | |
Q4  2013 | |||||
≡ | Thomas Gayner - Markel Group | Reduce 0.01% | 100 | 0.00 | |
Q3  2013 | |||||
≡ | David Abrams - Abrams Capital Management | Sell 100.00% | 2,561,269 | 5.82 | |
Q2  2013 | |||||
≡ | Harry Burn - Sound Shore | Sell 100.00% | 401,300 | 1.01 | |
Q4  2012 | |||||
≡ | David Katz - Matrix Asset Advisors | Reduce 3.23% | 1,500 | 0.11 | |
Q3  2012 | |||||
≡ | David Katz - Matrix Asset Advisors | Reduce 16.96% | 9,500 | 0.68 | |
Q2  2012 | |||||
≡ | David Rolfe - Wedgewood Partners | Sell 100.00% | 1,177,319 | 4.29 | |
Q1  2011 | |||||
≡ | Bruce Berkowitz - Fairholme Capital | Sell 100.00% | 177,400 | 0.07 | |
Q2  2009 | |||||
≡ | Bill & Melinda Gates Foundation Trust | Sell 100.00% | 277,595 | 0.15 | |
Q1  2008 | |||||
≡ | David Katz - Matrix Asset Advisors | Sell 100.00% | 108,000 | 3.13 | |
Q4  2007 | |||||
≡ | David Katz - Matrix Asset Advisors | Reduce 30.10% | 46,500 | 1.35 | |
Q3  2007 | |||||
≡ | David Katz - Matrix Asset Advisors | Reduce 20.77% | 40,500 | 0.88 | |
Q1  2007 | |||||
≡ | David Katz - Matrix Asset Advisors | Reduce 4.98% | 10,000 | 0.20 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.